Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biologics and airway remodeling in severe asthma
Gilda Varricchi, Sebastian Ferri, J. Pepys, et al.
Allergy (2022) Vol. 77, Iss. 12, pp. 3538-3552
Open Access | Times Cited: 131

Showing 1-25 of 131 citing articles:

Type 2 chronic inflammatory diseases: targets, therapies and unmet needs
Pavel Kolkhir, Cezmi A. Akdiş, Mübeccel Akdiş, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 9, pp. 743-767
Closed Access | Times Cited: 55
Airway remodelling in asthma and the epithelium: on the edge of a new era
Gilda Varricchi, Christopher E. Brightling, Christopher Grainge, et al.
European Respiratory Journal (2024) Vol. 63, Iss. 4, pp. 2301619-2301619
Open Access | Times Cited: 19
Airway hyperresponsiveness in asthma: The role of the epithelium
Peter Bradding, Celeste Porsbjerg, Andréanne Côté, et al.
Journal of Allergy and Clinical Immunology (2024) Vol. 153, Iss. 5, pp. 1181-1193
Open Access | Times Cited: 16
Efficacy of dupilumab for airway hypersecretion and airway wall thickening in patients with moderate-to-severe asthma: A prospective, observational study
Tomoko Tajiri, Motohiko Suzuki, Hirono Nishiyama, et al.
Allergology International (2024) Vol. 73, Iss. 3, pp. 406-415
Open Access | Times Cited: 12
Features of severe asthma response to anti-IL5/IL5r therapies: identikit of clinical remission
Giovanna Elisiana Carpagnano, Andrea Portacci, Santi Nolasco, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 11
Targeting Asthma Remission as the Next Therapeutic Step Toward Improving Disease Control
William W. Busse, Geoffrey Chupp, Thomas Corbridge, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 4, pp. 894-903
Open Access | Times Cited: 9
TSLP is localized in and released from human lung macrophages activated by T2-high and T2-low stimuli: relevance in asthma and COPD
Luisa Canè, Remo Poto, Francesco Palestra, et al.
European Journal of Internal Medicine (2024) Vol. 124, pp. 89-98
Closed Access | Times Cited: 9
The role of epithelial cells in fibrosis: Mechanisms and treatment
Liuyi Luo, Wei Zhang, Siyao You, et al.
Pharmacological Research (2024) Vol. 202, pp. 107144-107144
Open Access | Times Cited: 8
Mast cells: a novel therapeutic avenue for cardiovascular diseases?
Remo Poto, Gianni Marone, Stephen J. Galli, et al.
Cardiovascular Research (2024) Vol. 120, Iss. 7, pp. 681-698
Open Access | Times Cited: 7
Recent Developments in the Role of Histone Acetylation in Asthma
Daniel P. Potaczek, Stanisława Bazan‐Socha, Ewa Wypasek, et al.
International Archives of Allergy and Immunology (2024) Vol. 185, Iss. 7, pp. 641-651
Closed Access | Times Cited: 6
Biologics in severe asthma: a state-of-the-art review
Bishal Gyawali, Steve N. Georas, Sandhya Khurana
European Respiratory Review (2025) Vol. 34, Iss. 175, pp. 240088-240088
Open Access
A real-world study to evaluate effectiveness of mepolizumab in treating severe asthma in Taiwan (REMIT)
Shih-Lung Cheng, Shu‐Min Lin, Chung‐Kan Peng, et al.
Therapeutic Advances in Respiratory Disease (2025) Vol. 19
Open Access
Inhaling arsenic aggravates airway hyperreactivity by upregulating PNEC-sourced 5-HT in OVA-induced allergic asthma
Xue Lu, Zhu-Xia Tan, Yaxin Yao, et al.
Ecotoxicology and Environmental Safety (2025) Vol. 290, pp. 117764-117764
Open Access
Regional challenges to optimize the management of patients with severe asthma type 2 inflammation: a Delphi consensus in seven countries
Liam G. Heaney, Désirée Larenas‐Linnemann, Riyad Al‐Lehebi, et al.
Journal of Asthma (2025), pp. 1-16
Open Access
Trajectories of responses to mepolizumab in severe asthma
Santi Nolasco, Manali Mukherjee, Parameswaran Nair
European Respiratory Journal (2025) Vol. 65, Iss. 1, pp. 2402023-2402023
Closed Access
Assessing Serum and Biopsy Biomarkers for Predicting Allergic Asthma Severity: A Comprehensive Study
Zainab Khaleel Mohammed, Shukur Wasman Smail, Christer Janson, et al.
Journal of Asthma (2025), pp. 1-12
Closed Access
Pulmonary inflammation and fibroblast immunoregulation: from bench to bedside
Mohamed A. Ghonim, David F. Boyd, Tim Flerlage, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 17
Open Access | Times Cited: 19
Biologics in severe asthma: A pragmatic approach for choosing the right treatment for the right patient
Linda Rogers, Miloš Jeseňák, Leif Bjermer, et al.
Respiratory Medicine (2023) Vol. 218, pp. 107414-107414
Open Access | Times Cited: 19
Severe asthma clinical remission after biologic treatment with anti-IL4/IL13: A real-life experience
Andrea Portacci, Ilaria Iorillo, Vitaliano Nicola Quaranta, et al.
Respiratory Medicine (2023) Vol. 217, pp. 107348-107348
Closed Access | Times Cited: 17
Strain stiffening retards growth instability in residually stressed biological tissues
Yafei Wang, Yangkun Du, Fan Xu
Journal of the Mechanics and Physics of Solids (2023) Vol. 178, pp. 105360-105360
Closed Access | Times Cited: 15
Exosomes From IgE-Stimulated Mast Cells Aggravate Asthma-Mediated Atherosclerosis Through circRNA CDR1as-Mediated Endothelial Cell Dysfunction in Mice
Hongqin Yang, Junye Chen, Siyang Liu, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2024) Vol. 44, Iss. 3
Closed Access | Times Cited: 5
IgE in allergy: It takes two
Anouk von Borstel, Robyn E. O’Hehir, Menno C. van Zelm
Science Translational Medicine (2024) Vol. 16, Iss. 733
Closed Access | Times Cited: 5
Crosstalk between ROS-inflammatory gene expression axis in the progression of lung disorders
Sumel Ashique, Neeraj Mishra, Shubhrajit Mantry, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access | Times Cited: 4
Severe Asthma and Biological Therapies: Now and the Future
Olaia Sardón, Carolina Díaz‐García, Paula Corcuera, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 18, pp. 5846-5846
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top